Endothelial dysfunction and circulating microparticles in patients with antiphospholipid antibodies
| Errataetall: |
CommentOn: Med Clin (Barc). 2011 Apr 16;136(10):431-3. - PMID 21051055 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:138 |
|---|---|
| Enthalten in: |
Medicina clinica - 138(2012), 3 vom: 18. Feb., Seite 134-5 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Disfunción endotelial y micropartículas circulantes en pacientes con anticuerpos antifosfolipídicos |
|---|
| Beteiligte Personen: |
Alijotas-Reig, Jaume [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Antiphospholipid |
|---|
| Anmerkungen: |
Date Completed 27.07.2012 Date Revised 01.12.2018 published: Print-Electronic CommentOn: Med Clin (Barc). 2011 Apr 16;136(10):431-3. - PMID 21051055 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.medcli.2011.05.020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM211680761 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM211680761 | ||
| 003 | DE-627 | ||
| 005 | 20231224014050.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2012 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.medcli.2011.05.020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0706.xml |
| 035 | |a (DE-627)NLM211680761 | ||
| 035 | |a (NLM)21940006 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Alijotas-Reig, Jaume |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endothelial dysfunction and circulating microparticles in patients with antiphospholipid antibodies |
| 246 | 3 | 3 | |a Disfunción endotelial y micropartículas circulantes en pacientes con anticuerpos antifosfolipídicos |
| 264 | 1 | |c 2012 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.07.2012 | ||
| 500 | |a Date Revised 01.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Med Clin (Barc). 2011 Apr 16;136(10):431-3. - PMID 21051055 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Antiphospholipid |2 NLM | |
| 650 | 7 | |a von Willebrand Factor |2 NLM | |
| 700 | 1 | |a Palacio-García, Carlos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina clinica |d 1948 |g 138(2012), 3 vom: 18. Feb., Seite 134-5 |w (DE-627)NLM000359017 |x 1578-8989 |7 nnns |
| 773 | 1 | 8 | |g volume:138 |g year:2012 |g number:3 |g day:18 |g month:02 |g pages:134-5 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medcli.2011.05.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 138 |j 2012 |e 3 |b 18 |c 02 |h 134-5 | ||